BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36433862)

  • 21. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
    Shimizu S; Ohira M; Nakano R; Imaoka Y; Sato K; Tahara H; Ide K; Kobayashi T; Kuroda S; Ono H; Tanaka Y; Ohdan H
    Transplant Proc; 2019 Oct; 51(8):2740-2744. PubMed ID: 31563243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.
    Nasr G; Hassan A; Ahmed S; Serwah A
    J Cardiovasc Dis Res; 2010 Jul; 1(3):136-44. PubMed ID: 21187868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
    Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study.
    Romney R; Mathurin P; Ganne-Carrié N; Halimi C; Medini A; Lemaitre P; Gruaud P; Jouannaud V; Delacour T; Boudjema H; Pauwels A; Chaput JC; Cadranel JF
    Gastroenterol Clin Biol; 2005 Mar; 29(3):275-9. PubMed ID: 15864178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.
    Bari K; Miñano C; Shea M; Inayat IB; Hashem HJ; Gilles H; Heuman D; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1169-75. PubMed ID: 22801062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
    Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
    J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
    Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
    BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.
    Takahashi H; Sakai R; Fujita A; Kuwabara H; Hattori Y; Matsuura S; Ohshima R; Hagihara M; Tomita N; Ishigatsubo Y; Fujisawa S
    Artif Organs; 2013 Oct; 37(10):932-6. PubMed ID: 23692354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient.
    Maeda A; Takeda K; Tsuruya K; Miura S; Toyonaga J; Nakashita S; Furushou M; Mukai H; Mutou Y; Komaki T; Takae K; Yasunaga C
    Case Rep Nephrol Urol; 2012 Jul; 2(2):138-44. PubMed ID: 23289021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascites.
    Garcia N; Sanyal AJ
    Curr Treat Options Gastroenterol; 2001 Dec; 4(6):527-537. PubMed ID: 11696279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.
    Chang SC; Chang HI; Chen FJ; Shiao GM; Wang SS; Lee SD
    J Hepatol; 1997 Apr; 26(4):833-8. PubMed ID: 9126796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Ascites.
    Choudhury J; Sanyal AJ
    Curr Treat Options Gastroenterol; 2003 Dec; 6(6):481-491. PubMed ID: 14585237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
    Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
    Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic paracentesis with albumin infusion for the treatment of tension ascites in cirrhotic patients. Preliminary report].
    García Compean D; Pérez Martínez C; Guerra JM; Barragán RF
    Rev Gastroenterol Mex; 1990; 55(1):7-12. PubMed ID: 2291066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis.
    Yakar T; Demir M; Dogan O; Parlakgumus A; Ozer B; Serin E
    Clin Invest Med; 2016 Dec; 39(6):27502. PubMed ID: 27917793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites].
    Xing F; Li S; Zhang JJ; Sun CY; Huang JR; Gao ZL; Zhu TT; Zhao Q; Zhang H; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):982-988. PubMed ID: 31941260
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical Performance and Clinical Effectiveness of Drop Type With Adjustable Concentrator-Cell Free and Concentrated Ascites Reinfusion Therapy.
    Yamada Y; Harada M; Yamaguchi A; Kobayashi Y; Chino T; Minowa T; Kosuge T; Tsukada W; Hashimoto K; Kamijo Y
    Artif Organs; 2017 Dec; 41(12):1135-1144. PubMed ID: 28589706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.